rs574401853
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_016010.3(ZC2HC1A):c.502G>C(p.Val168Leu) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000351 in 1,425,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/24 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016010.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- epidermodysplasia verruciformisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- epidermodysplasia verruciformis, susceptibility to, 5Inheritance: AR Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000180 AC: 4AN: 222400 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000351 AC: 5AN: 1425090Hom.: 0 Cov.: 31 AF XY: 0.00000141 AC XY: 1AN XY: 708556 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.502G>C (p.V168L) alteration is located in exon 5 (coding exon 5) of the ZC2HC1A gene. This alteration results from a G to C substitution at nucleotide position 502, causing the valine (V) at amino acid position 168 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at